Arvinas - Stock Price History | ARVN

Historical daily share price chart and data for Arvinas since 2021 adjusted for splits. The latest closing stock price for Arvinas as of October 27, 2021 is 83.07.
  • The all-time high Arvinas stock closing price was 107.87 on July 29, 2021.
  • The Arvinas 52-week high stock price is 108.47, which is 30.6% above the current share price.
  • The Arvinas 52-week low stock price is 20.50, which is 75.3% below the current share price.
  • The average Arvinas stock price for the last 52 weeks is 71.86.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Arvinas Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 38.0874 41.4400 84.9300 20.1900 84.9300 106.69%
2019 23.2150 13.8100 44.3800 13.5500 41.0900 219.77%
2018 15.8814 16.0500 18.5600 11.1900 12.8500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.194B $0.022B
Arvinas Inc. is a biopharmaceutical company for patients suffering from debilitating and life-threatening diseases. It engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Arvinas Inc. is based in CT, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86